{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:00:47Z","timestamp":1789952447475,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd007063","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T00:00:00Z","timestamp":1283904000000}}],"reference-count":71,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007063.pub2","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T15:34:29Z","timestamp":1283441669000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women"],"prefix":"10.1002","volume":"2010","author":[{"given":"Sharif I","family":"Ismail","sequence":"first","affiliation":[{"name":"Singleton Hospital; Department of Obstetrics and Gynaecology; Swansea Wales UK SA2 8QA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bain","sequence":"additional","affiliation":[{"name":"Aberdeen Royal Infirmary; Foresterhill Aberdeen UK AB25 2ZD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Hagen","sequence":"additional","affiliation":[{"name":"Glasgow Caledonian University; Nursing, Midwifery and Allied Health Professions Research Unit; Glasgow UK G4 0BA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9,8]]},"reference":[{"key":"10.1002\/14651858.CD007063.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-5122(92)90208-L","article-title":"Preoperative treatment with oestradiol in women scheduled for vaginal operation for genital prolapse: a randomised double blind trial","volume":"15","author":"Felding","year":"1992","journal-title":"Maturitas"},{"issue":"2","key":"10.1002\/14651858.CD007063.pub2-BIB0002|cit2","first-page":"125","article-title":"Clinical effects of preoperative oestradiol treatment before vaginal repair operation. A double-blind, randomized trial","volume":"40","author":"Mikkelsen","year":"1995","journal-title":"Gynecologic & Obstetric Investigation"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0005|cit5","first-page":"91","article-title":"Raloxifene effect on frequency of surgery for pelvic floor relaxation","volume":"98","author":"Goldstein","year":"2001","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1001\/archinte.160.22.3444","article-title":"Long term effects of raloxifene on bone mineral density, bone turnover and serum lipid levels in early postmenopausal women: three-year data from 2 double blind randomized placebo controlled trials","volume":"160","author":"Johnston","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0007|cit7","unstructured":"Valente M Dettori C Feraudo E Re ME Pelvic-floor: new therapeutic approach (Abstract number IDP66) International Urogynecology Journal YR:2000 S97"},{"issue":"1","key":"10.1002\/14651858.CD007063.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1067\/mob.2003.374","article-title":"Short term urogenital effects of raloxefine, tomoxifen and estrogen","volume":"189","author":"Vardy","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007063.pub2-BIB0009|cit9","first-page":"S33","article-title":"Short term urogenital effects of raloxifene, tamoxifen, and estrogen (Abstract number 15)","volume":"12","author":"Vardy","year":"2001","journal-title":"International Urogynecology Journal"},{"issue":"2","key":"10.1002\/14651858.CD007063.pub2-BIB0010|cit10","first-page":"281","article-title":"Sexual function in women with urinary incontinence and pelvic organ prolapse","volume":"99","author":"Barber","year":"2002","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD007063.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1933719106298684","article-title":"Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol or estriol plus medroxyprogesterone acetate","volume":"14","author":"Verheul","year":"2007","journal-title":"Reproductive Sciences"},{"issue":"2","key":"10.1002\/14651858.CD007063.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurology and Urodynamics"},{"issue":"2","key":"10.1002\/14651858.CD007063.pub2-BIB0013|cit13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004010.pub2","article-title":"Mechanical devices for pelvic organ prolapse in women","author":"Adams","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0968-8080(04)23110-X","article-title":"Listening to ''felt needs'': investigating genital prolapse in western Nepal","volume":"12","author":"Bonetti","year":"2004","journal-title":"Reproductive Health Matters"},{"issue":"4","key":"10.1002\/14651858.CD007063.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.AOG.0000180183.03897.72","article-title":"Vaginal wall descensus and pelvic floor symptoms in older women","volume":"106","author":"Bradley","year":"2005","journal-title":"Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD007063.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/01.AOG.0000255977.91296.5d","article-title":"Natural history of pelvic organ prolapse in postmenopausal women","volume":"109","author":"Bradley","year":"2007","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2265.1995.tb02660.x","article-title":"An audit of oestradiol levels and implant frequency in women undergoing subcutaneous implant therapy","volume":"42","author":"Buckler","year":"1995","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD007063.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0002-9378(96)70243-0","article-title":"The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction","volume":"175","author":"Bump","year":"1996","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1067\/mob.2000.105410","article-title":"Urinary incontinence and pelvic organ prolapse in women with Marfan or Ehlers Danlos syndrome","volume":"182","author":"Carley","year":"2000","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s001920050040","article-title":"Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study","volume":"10","author":"Casper","year":"1999","journal-title":"International Urogynecology Journal"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.ajog.2004.12.083","article-title":"Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial","volume":"192","author":"Chalas","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/15246090152636541","article-title":"Oestrogen, progesterone and androgen receptor expression in levator ani muscle and fascia","volume":"10","author":"Copas","year":"2001","journal-title":"Journal of Womens Health and Gender-Based Medicine"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00003081-199312000-00014","article-title":"Pelvic organ prolapse: a clinical management and scientific foundation","volume":"36","author":"DeLancey","year":"1993","journal-title":"Clinical Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/mob.2002.125733","article-title":"Fascial and muscular abnormalities in women with urethral hypermobility and anterior vaginal wall prolapse","volume":"187","author":"Delancey","year":"2002","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1200\/JCO.2007.14.0921","article-title":"Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control study","volume":"26","author":"DeMichele","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD007063.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1471-0528.2005.00568.x","article-title":"The relationship of vaginal prolapse severity to symptoms and quality of life","volume":"112","author":"Digesu","year":"2005","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD007063.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0028-2243(92)90059-8","article-title":"Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study","volume":"44","author":"Eriksen","year":"1992","journal-title":"European Journal of Obstetrics, Gynecology & Reproductive Biology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bmj.300.6722.436","article-title":"Prolonged endometrial stimulation associated with oestradiol implants","volume":"300","author":"Gangar","year":"1990","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD007063.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ajog.2004.12.004","article-title":"Pelvic organ descent and symptoms of pelvic floor disorders","volume":"193","author":"Ghetti","year":"2005","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD007063.pub2-BIB0032|cit32","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003882.pub3","article-title":"Conservative management of pelvic organ prolapse in women","author":"Hagen","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/00016348209156956","article-title":"Estrogenic potency of oral replacement therapy estimated by the induction of pregnancy zone protein","volume":"61","author":"Helgason","year":"1982","journal-title":"Acta Obstetrica et Gynecologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD007063.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1067\/mob.2002.123819","article-title":"Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity","volume":"186","author":"Hendrix","year":"2002","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"7414","key":"10.1002\/14651858.CD007063.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0036|cit36","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. In: The Cochrane Library, Issue 4, 2006","author":"Higgins","year":"2006"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/13697130601024629","article-title":"A study of women on long-term hormone replacement therapy and their attitude to suggested cessation","volume":"9","author":"Horner","year":"2006","journal-title":"Climacteric"},{"issue":"5","key":"10.1002\/14651858.CD007063.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ajog.2006.01.060","article-title":"Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life","volume":"2006","author":"Jelovsek","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1001\/archinte.160.22.3444","article-title":"Long term effects of raloxifene on bone mineral density, bone turnover and serum lipid levels in early postmenopausal women: three-year data from 2 double blind randomized placebo controlled trials","volume":"160","author":"Johnston","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0020-7292(02)00232-1","article-title":"Oestrogen levels and oestrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse","volume":"80","author":"Lang","year":"2003","journal-title":"International Journal of Gynaecology & Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD007063.pub2-BIB0041|cit41","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001395.pub3","article-title":"Phytoestrogens for vasomotor menopausal symptoms","author":"Lethaby","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007063.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.fertnstert.2005.06.042","article-title":"A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women","volume":"85","author":"Long","year":"2006","journal-title":"Fertility and sterility"},{"issue":"6","key":"10.1002\/14651858.CD007063.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/01.AOG.0000218096.54169.34","article-title":"Parity, mode of delivery, and pelvic floor disorders","volume":"107","author":"Lukacz","year":"2006","journal-title":"Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD007063.pub2-BIB0044|cit44","article-title":"Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes","author":"MacLennan","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007063.pub2-BIB0045|cit45","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004014.pub4","article-title":"Surgical management of pelvic organ prolapse in women","author":"Maher","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0046|cit46","first-page":"111","article-title":"Local oestrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose 17beta-estradiol vaginal tablets","volume":"32","author":"Mainini","year":"2005","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejogrb.2006.01.025","article-title":"Transvaginal color Doppler sonographic assessment of uterus and ovaries in postmenopausal women: the effect of local oestrogen treatment","volume":"127","author":"Manonai","year":"2006","journal-title":"European Journal of Obstetrics, Gynecology & Reproductive Biology"},{"issue":"2","key":"10.1002\/14651858.CD007063.pub2-BIB0048|cit48","first-page":"125","article-title":"Clinical effects of preoperative oestradiol treatment before vaginal repair operation. A double-blind, randomized trial","volume":"40","author":"Mikkelsen","year":"1995","journal-title":"Gynecologic & Obstetric Investigation"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0029-7844(97)00058-6","article-title":"Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence","volume":"89","author":"Olsen","year":"1997","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0050|cit50","first-page":"253","article-title":"Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement","volume":"10","author":"Persson","year":"1999","journal-title":"Cancer Causes and Control"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1532-5415.1981.tb01274.x","article-title":"Management of incarcerated vaginal pessaries","volume":"29","author":"Poma","year":"1981","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/09513590312331290338","article-title":"Synthetic oestrogen-medicated activation of ERK2 intracellular signalling molecule","volume":"17","author":"Prifti","year":"2003","journal-title":"Gynecological Endrocrinology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2125.2006.02656.x","article-title":"Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women","volume":"62","author":"Rad","year":"2006","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD007063.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/bjs.4065","article-title":"Pelvic connective tissue resilience decreases with vaginal delivery, menopause and uterine prolapse","volume":"90","author":"Reay Jones","year":"2003","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.maturitas.2007.01.001","article-title":"One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women","volume":"57","author":"Samsioe","year":"2007","journal-title":"Maturitas"},{"issue":"4","key":"10.1002\/14651858.CD007063.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1471-0528.2002.01109.x","article-title":"Epidemiology of pelvic organ prolapse in rural Gambia, West Africa","volume":"190","author":"Scherf","year":"2002","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/OGX.0b013e31816400d7","article-title":"Selective estrogen receptor modulators: an update on recent clinical findings","volume":"63","author":"Shelly","year":"2008","journal-title":"Obstetrical and Gynecological Survey"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/13697139909038087","article-title":"Selective estrogen receptor modulators: tissue selectivity and differential uterine effects","volume":"2","author":"Silfen","year":"1999","journal-title":"Climacteric"},{"issue":"4","key":"10.1002\/14651858.CD007063.pub2-BIB0059|cit59","first-page":"313","article-title":"Bowel dysfunction: a pathogenic factor in uterovaginal prolapse and urinary stress incontinence","volume":"11","author":"Spence-Jones","year":"1994","journal-title":"Neurourology & Urodynamics"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/0301-2115(95)02353-4","article-title":"Handling hormone replacement therapy: key issues for the prescriber","volume":"64","author":"Stevenson","year":"1996","journal-title":"European Journal of Obstetrics, Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD007063.pub2-BIB0061|cit61","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001500.pub2","article-title":"Local oestrogen for vaginal atropy in postmenopausal women","author":"Suckling","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9378(93)90291-P","article-title":"Sustained-release subdermal estradiol implants: a new alternative in oestrogen replacement therapy","volume":"169","author":"Suhonen","year":"1993","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0063|cit63","first-page":"758","article-title":"Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone","volume":"77","author":"Suvanto-Luukkonen","year":"1998","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD007063.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00192-005-1326-1","article-title":"Prevalence of symptomatic pelvic organ prolapse in a Swedish population","volume":"16","author":"Tegerstedt","year":"2005","journal-title":"International Urogynecology Journal"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0065|cit65","first-page":"349","article-title":"Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving oestrogen replacement therapy","volume":"56","author":"Campenhout","year":"1980","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjmed.2005.10.004","article-title":"Genitourinary symptoms in the menopausal transition","volume":"118 Suppl 12B","author":"Voorhis","year":"2005","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36); I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"1","key":"10.1002\/14651858.CD007063.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13697130500042490","article-title":"Vaginal rugae: measurement and significance","volume":"81","author":"Whiteside","year":"2005","journal-title":"Climacteric"},{"issue":"4","key":"10.1002\/14651858.CD007063.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00192-005-0009-2","article-title":"Prevalence of severe pelvic organ prolapse in relation to job description and socioeconomic status: a multicenter cross-sectional study","volume":"17","author":"Woodman","year":"2006","journal-title":"International Urogynecology Journal"},{"key":"10.1002\/14651858.CD007063.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3122\/jabfm.18.5.374","article-title":"Natural history of menopause symptoms in primary care patients: a MetroNet study","volume":"18","author":"Xu","year":"2005","journal-title":"Journal of the American Board of Family Practice"},{"issue":"6","key":"10.1002\/14651858.CD007063.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatrica Scandinavica"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007063.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:06:18Z","timestamp":1789949178000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007063.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Incontinence Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,9,8]]},"references-count":71,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007063.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,8]]}}}